Archiving & Indexing
All published articles are assigned to Digital Object Identifier (DOI)- CrossRef. iMedPub deposits publications in multiple digital archives around the world to guarantee long-term
digital preservation. We deposit all our publications at Medbrary, the online medical library. We
make daily back-up of the files in our server to ensure all manuscripts and articles can be recovered at any moment in case of accident. All published articles are indexed in DOAJ,
Google Scholar, Scientific Common and Index Copernicus. All articles are permanently archived and available in HTML, XML and PDF formats.
iMedPub makes article metadata available in compliance with Open Archives Initiative protocols, enabling automated 'harvesting' of our research articles for inclusion in any other digital archives. We support non-exclusive digital archiving of research articles by as many international archives as possible, to ensure the security and permanent accessibility of that research.
iMedPub is a participant in the LOCKSS (Lots of Copies Keep Stuff Safe) initiative. LOCKSS will enable any library to maintain their own archive of content from iMedPub and other publishers, with minimal technical effort and using cheaply available hardware.
Subscribing & Distributing
Our titles are distributed by Ingram (MyiLibrary), Deepdyve, Scribd, La Casa del Libro, Díaz de Santos and e-Livros/eLibros among others. Subscriptions can be made online in the journal's
website or in EBSCO and other subscription agents. We specially encourage readers to subscribe Medbrary, the online medical library, where all our titles are available.
Our journals support self-archiving. iMedPub journals permit and encourages authors to post items submitted to the journals on personal websites or institutional repositories both prior to and after publication, while providing bibliographic details that credit, if applicable, its publication in the journal .Publishing open access facilitates the free exchange of knowledge. Make your research visible and accessible to your peers by uploading a full-text version of this publication to your institution's archive or anywhere else. We support authors by posting the published version of articles by NIH grant-holders to PubMed Central immediately after publication (see an example of articles indexed in PubMed from our journal Translational Biomedicine).
Policies, Transparency and Best Practice
At iMedPub we take the conduct and ethical considerations of our authors, reviewers and editors very seriously, as well as our own responsibilities as owner and publisher. We follow the ICMJE recommendations for ethical standards in the conduct and reporting of research and other material published in medical journals. We also comply with policies from FundRef and CHORUS.
All iMedPub's journals adhere the principles of Transparency and Best Practice stated by the joint of The Committee on Publication Ethics, the Directory of Open Access Journals, the Open Access Scholarly Publishers Association, and the World Association of Medical Editors:
1. Peer review process: All of our journal’s content, apart from any editorial material that is clearly marked as such, shall be subjected to peer review. Peer review is defined as obtaining advice on individual manuscripts from reviewers expert in the field who are not part of the journal’s editorial staff. This process, as well as any policies related to the journal’s peer review procedures, shall be clearly described on the journal’s Web site.
2. Governing Body: Journals shall have editorial boards or other governing bodies whose members are recognized experts in the subject areas included within the journal’s scope. The full names and affiliations of the journal’s editors shall be provided on the journal’s web site. All manuscripts undergo full peer-review by at least 2 external independent reviewers.
3. Editorial team/contact information: the full names and affiliations of the journal’s editors are provided on the journal’s website as well as contact information for the editorial office.
4. Author fees: Any fees or charges that are required for manuscript processing and/or publishing materials in the journal are clearly stated here.
5. Copyright: Copyright and licensing information shall be clearly described on the journal’s website, and licensing terms shall be indicated on all published articles, both HTML and PDFs.
6. Identification of and dealing with allegations of research misconduct: iMedPub will take the measures to identify and prevent the publication of papers where research misconduct has occurred, including plagiarism, citation manipulation, and data falsification/fabrication, among others. In no case shall a journal or its editors encourage such misconduct, or knowingly allow such misconduct to take place. In the event that a journal’s publisher or editors are made aware of any allegation of research misconduct relating to a published article in their journal – the publisher or editor shall follow COPE’s guidelines (or equivalent) in dealing with allegations.
7. Ownership and management: Information about the ownership and/or management of our journals are clearly indicated on the journal’s website. Publishers shall not use organizational names that would mislead potential authors and editors about the nature of the journal’s owner.
8. Web sites: our journal’s websites, including the text that it contains, demonstrate that care has been taken to ensure high ethical and professional standards.
9. Name of journal: The name of our journals is unique and not be one that is easily confused with another journal or that might mislead potential authors and readers about the Journal’s origin or association with other journals.
10. Conflicts of interest: Our journals have clear policies on handling potential conflicts of interest of editors, authors, and reviewers and the policies should be clearly stated.
11. Access: The way(s) in which the journal and individual articles are available to readers and whether there are associated subscription or pay per view fees are stated.
12. Revenue sources: Business models or revenue sources (eg, author fees, subscriptions, advertising, reprints, institutional support, and organizational support) are be clearly stated under "Article Processing Charges".
13. Advertising: Journals shall state their advertising policy if relevant, including what types of ads will be considered, who makes decisions regarding accepting ads and whether they are linked to content or reader behavior (online only) or are displayed at random.
14. Publishing schedule: The periodicity at which a journal publishes shall be clearly indicated.
15. Archiving: A journal’s plan for electronic backup and preservation of access to the journal content (for example, access to main articles via CLOCKSS or PubMedCentral) in the event a journal is no longer published shall be clearly indicated.
We adhere the recommendations of WAME: Reprinted articles will be
published as they originally appeared in the journal (including subsequent corrections); that is, there is no alteration or revision of articles for a supplement or reprint other than
corrections. The content of special supplementary issues will be determined only by the usual editorial process and not be influenced in any way by the funding source or advertisers. All
our journals require all advertisements to clearly identify the advertiser and the product or service being offered. In the case of drug advertisements, the full generic name of each active
ingredient should appear. Commercial advertisements will not be placed adjacent to any editorial matter that discusses the product being advertised, nor adjacent to any article reporting
research on the advertised product, nor should they refer to an article in the same issue in which they appear. Exaggerated or extravagantly worded copy should will be allowed. We
reserve the right to refuse any advertisement for any reason. The decision as to acceptance (and any questions about eligibility raised by readers or others) will be made in
consultation with the journal's editorial content team and the editorial team should be regularly informed about the evaluation of advertising, especially those that are refused due to
non-compliance with the journal's guidelines.